News

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29
Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut ...
Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
Stocktwits on MSN3d
Kenvue CEO Thibaut Mongon Steps Down, Director Kirk Perry To Take On Interim CEO Role
Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry ...
Fierce Pharma2d
Consumer health giant Kenvue kicks off CEO transition as sales slip
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
European Supermarket Magazine3d
Kenvue Top Boss Thibaut Mongon Steps Down, Kirk Perry Named Interim CEO
Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing ...
Barchart on MSN3d
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a ...
Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...